Stock ownership · SEC 13F · Q3 2025

IMMUNITYBIO INC

Who owns IMMUNITYBIO INC (CUSIP 45256X103)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.

$368K
Reported value
4
Institutions
100%
Top-5 share

The verdict

As of Q3 2025, 4 institutions report $368K in IMMUNITYBIO INC positions, ownership that is dominated by its top few institutional owners.

4
institutions hold it
$368K
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 45256X103 · Q3 2025 $0M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-MID · BOOK-MID

  • VALUE-TRACE $0.4M
  • HOLDERS-FOCUS 4 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-MID 4 new
  • BOOK-MID 5Q history

Read with: Ownership concentration guide - IMMUNITYBIO INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of IMMUNITYBIO INC
  1. 1
    JPMORGAN CHASE & CO $243K
  2. 2
    CIBC Bancorp USA Inc. $60K
  3. 3
    Alpine Global Management, LLC $56K
  4. 4
    CIBC Private Wealth Group LLC $9K

Top 4 reported holders by value · Q3 2025

Institutional ownership over time

The number of institutions reporting a IMMUNITYBIO INC position has risen from 2 to 4 over the last 5 quarters of 13F filings.

012345 Q3'24Q4'24Q1'25Q2'25Q3'25 4
Distinct 13F filers holding IMMUNITYBIO INC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) 98,644 $243K 66.0%
2 CIBC Bancorp USA Inc. 24,521 $60K 16.4%
3 Alpine Global Management, LLC 22,753 $56K 15.2%
4 CIBC Private Wealth Group LLC 3,500 $9K 2.3%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among IMMUNITYBIO INC's reported holders for Q3 2025, by reported value:

Shared-defined discretion (DFND)
82.4%
Sole discretion (SOLE)
17.6%

Latest Quarter Activity · Q3 2025

New positions (4)

JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) $243K
CIBC Bancorp USA Inc. $60K
Alpine Global Management, LLC $56K
CIBC Private Wealth Group LLC $9K

Complete exits (1)

China Universal Asset Management Co., Ltd. exited

Frequently Asked Questions

How many institutions hold IMMUNITYBIO INC?▼
IMMUNITYBIO INC is held by 4 institutional investors per the latest SEC Form 13F filings as of Q3 2025.
What is the total institutional value of IMMUNITYBIO INC?▼
Institutions report $368K of IMMUNITYBIO INC as of Q3 2025.
How concentrated is ownership of IMMUNITYBIO INC?▼
The top five institutional holders account for 100% of the reported institutional value in IMMUNITYBIO INC, making ownership dominated by its top few institutional owners.
Who is the largest institutional holder of IMMUNITYBIO INC?▼
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) is the largest reported holder of IMMUNITYBIO INC with $243K across 98,644 shares as of Q3 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.